Stock listing
NASDAQ:RVNC Revance Therapeutics, Inc. Stock
Follow Revance Therapeutics, Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:RVNC
$3.65 USD
Close on Feb 6, 2025 · No longer trades
- Lowest – highest close
- $2.34 – $40.78 USDSince Feb 6, 2014 · lowest Jun 26, 2024 · highest Nov 11, 2015
Delisted NASDAQ:RVNC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RVNC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
Revance Debuts DAXXIFY® Streaming TV Spot, "Relatable Moments," Bringing Honest Aesthetics Conversations to a Wider Audience
Latest news
Revance Therapeutics, Inc. on 6ix
- News releases
- 1 in the last 12 months · 1 in all · newest Nov 16, 2026 · oldest 2026
- Calls
- 13 calls with a replay · 13 with a transcript · latest May 9, 2024
- Decks
- 10 decks · latest Sep 19, 2023
Events
| Call | When | Status |
|---|---|---|
| Revance Therapeutics (RVNC) Q1 2024 Earnings Call | Thu, May 09, 2024 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q4 2023 Earnings Call | Wed, Feb 28, 2024 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q2 2023 Earnings Call | Tue, Aug 08, 2023 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q1 2023 Earnings Call | Tue, May 09, 2023 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q4 2022 Earnings Call | Tue, Feb 28, 2023 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q1 2022 Earnings Call | Tue, May 10, 2022 · 7:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q4 2021 Earnings Call | Mon, Feb 28, 2022 · 4:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 7:30 PM ET | Replay |
All 13 calls
| Call | When | Status |
|---|---|---|
| Revance Therapeutics (RVNC) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 7:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q1 2021 Earnings Call | Mon, May 10, 2021 · 7:30 PM ET | Replay |
| Revance Therapeutics (RVNC) Q4 2020 Earnings Call | Mon, Feb 22, 2021 · 7:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (September 2023) | Investor day | 112 slides | Sep 19, 2023 |
| Technical Presentation (October 2020) | Technical | 28 slides | Oct 14, 2020 |
| Merger or Acquisition (May 2020) | Merger or acquisition | 28 slides | May 19, 2020 |
| Technical Presentation (December 2018) | Technical | 37 slides | Dec 4, 2018 |
| Investor Day (April 2018) | Investor day | 106 slides | Apr 19, 2018 |
| Technical Presentation (December 2017) | Technical | 28 slides | Dec 5, 2017 |
| Jefferies 2017 Global Healthcare Conference | Conference | 30 slides | Jun 6, 2017 |
| Technical Presentation (May 2017) | Technical | 12 slides | May 18, 2017 |
| Technical Presentation (December 2016) | Technical | 15 slides | Dec 12, 2016 |
| Technical Presentation (October 2015) | Technical | 18 slides | Oct 29, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Vlad Coric Other companies: Veradermics, Incorporated (Board Member · Since at least Feb 3, 2026); Royalty Pharma plc (Director · Since at least Apr 7, 2025); Biohaven Ltd. (Chairman & Chief Executive Officer · Since at least Sep 22, 2022); Akili Inc (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Biohaven Pharmaceutical Holding Co Ltd (Chief Executive Officer, Director · May 3, 2017 – Oct 3, 2022 · Past) | Director · Mar 1, 2023 – Feb 4, 2025 · Past |
| Jill Beraud Other companies: Levi Strauss & Co (Director · Since at least Mar 20, 2019); Tiffany & Co (EXECUTIVE VICE PRESIDENT · Oct 13, 2014 – Jan 26, 2015 · Past); RTW Retailwinds Inc (Director · May 2, 2011 – Jun 16, 2014 · Past) | Director · Jun 4, 2019 – Feb 4, 2025 · Past |
| Caryn Gordon McDowell Other companies: Quince Therapeutics, Inc. (Chief Legal & Adm. Officer · May 5, 2020 – Jun 6, 2022 · Past); Cytokinetics, Incorporated (GC & Chief Compliance Officer · May 18, 2016 – Feb 27, 2018 · Past) | SVP, GC & Secretary · May 1, 2018 – Feb 15, 2020 · Past |
| Mark J. Foley Other companies: Glaukos Corporation (Director · Since at least Dec 13, 2017); SI-BONE, Inc. (Director · Jun 13, 2019 – Jun 16, 2020 · Past) | President & CEO, Director · Nov 7, 2017 – Feb 4, 2025 · Past |
| Olivia Ware Other companies: Contineum Therapeutics, Inc. (Director · Since at least Apr 4, 2024); Arcellx Inc (Director · Since at least May 16, 2022) | Director · Mar 6, 2021 – Feb 4, 2025 · Past |
| Tobin Schilke Other companies: Crinetics Pharmaceuticals, Inc. (Chief Financial & Infra. Ofcr. · Since at least Feb 28, 2025); Achaogen Inc (Chief Financial Officer · Jul 5, 2016 – Jun 26, 2018 · Past) | CFO · Nov 5, 2018 – Feb 4, 2025 · Past |
| James Walter Glasheen Other companies: Soleno Therapeutics, Inc. (Director · Jul 6, 2017 – Jun 11, 2018 · Past) | Director · Feb 5, 2014 – May 5, 2016 · Past |
| Ronald J Wooten Other companies: Aceragen Inc. (Director · Sep 28, 2022 – Jan 17, 2023 · Past) | Director · Feb 5, 2014 – May 7, 2015 · Past |
| Abhay Joshi | COO, President of R&D · Dec 14, 2015 – Mar 15, 2022 · Past |
| Aubrey Rankin | Director · Jul 23, 2020 – Mar 15, 2022 · Past |
All 12 people
| Person | Seat |
|---|---|
| Carey OConnor Kolaja | Director · May 1, 2024 – Feb 4, 2025 · Past |
| Curtis Ruegg | EVP, Technical Operations · Feb 5, 2014 – Jun 13, 2016 · Past |
Log in to ask 6ix AI your own questions about Revance Therapeutics, Inc.